Abstract
Objective: PD-1 is an immunoinhibitory receptor which plays vital role in pathogenesis of hepatitis B virus (HBV) infection. The aim of this study was to understand the relationship between PD-1.1 polymorphism in HBV infection and liver disease progression. Subject and method: 154 chronic hepatitis B virus (CHB), 127 liver cirrhosis (LC), 186 hepatocellular carcinoma (HCC) and 160 healthy controls. The PD-1.1 polymorphism was genotyped by directed Sanger sequencing. Result: The PD-1.1 TT genotype was found to be a risk factor for LC predisposition of CHB patients. Conclusion: The PD-1.1 polymorphisms are related to the progession of HBV-related liver disease, especially as a prognostic factor for cirrhosis liver in patients with chronic hepatitis B.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
